XENE - Xenon Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

XENE is currently covered by 14 analysts with an average price target of $72.22. This is a potential upside of $34.81 (93.05%) from yesterday's end of day stock price of $37.41.

Xenon Pharmaceuticals's activity chart (see below) currently has 165 price targets and 155 ratings on display. The stock rating distribution of XENE is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 87.5% with an average time for these price targets to be met of 519.84 days.

Highest price target for XENE is $100, Lowest price target is $46, average price target is $72.22.

Most recent stock forecast was given by YATIN SUNEJA from GUGGENHEIM on 06-Oct-2026. First documented stock forecast 01-Dec-2014.

Best performing analysts who are covering XENE - Xenon Pharmaceuticals:

David Hoang Tessa Romero Charles Duncan Paul Choi Joshua Schimmer Rudy Li Brian Abrahams

Currently out of the existing stock ratings of XENE, 36 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 20-Sep-2019

$73

$35.59 (95.13%)

$90

26 days ago
(06-Oct-2026)

4/6 (66.67%)

$36.43 (99.62%)

563

Buy Since 24-Mar-2020

$55

$17.59 (47.02%)

$63

1 months 14 days ago
(18-Sep-2026)

17/18 (94.44%)

$15.25 (38.36%)

402

Buy Since 03-Sep-2025

$64

$26.59 (71.08%)

$69

1 months 14 days ago
(18-Sep-2026)

6/7 (85.71%)

$24.25 (61.01%)

79

Buy Since 08-Dec-2023

$90

$52.59 (140.58%)

$97

1 months 14 days ago
(18-Sep-2026)

1/3 (33.33%)

$50.25 (126.42%)

942

Buy Since 03-Jan-2024

$46

$8.59 (22.96%)

$60

1 months 14 days ago
(18-Sep-2026)

4/5 (80%)

$6.25 (15.72%)

588

Show more analysts

Please expand the browser size to see the chart

What is XENE (Xenon Pharmaceuticals) average time for price targets to be met?

On average it took 520 days for the stock forecasts to be reached, with an average price target met ratio of 87.5%.

Which analyst most recently updated their price target on XENE (Xenon Pharmaceuticals)?

Yatin Suneja

Which analyst has the most public recommendations on XENE (Xenon Pharmaceuticals)?

Yatin Suneja works at GUGGENHEIM and has 6 price targets and 6 ratings on XENE

Which analyst is the currently most bullish on XENE (Xenon Pharmaceuticals)?

Andrew Tsai with the highest potential upside of $62.59

Which analyst is the currently most reserved on XENE (Xenon Pharmaceuticals)?

Hugo Ong with the lowest potential downside of -$25.02
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?